Results 211 to 220 of about 5,541,707 (291)
Reduced Levels of Resolvin D1 and Thrombospondin-1 in Vernal Keratoconjunctivitis. [PDF]
Konuk ŞG +5 more
europepmc +1 more source
Daily prospective symptom reports from participants in this multicentre observational study were compared to retrospective (last 12 months) reports based on ARIA clinical questionnaire. Retrospective reports substantially underestimated, and to a lesser extent overestimated, symptom frequency compared to e‐Diary prospective reports. Since retrospective
Stephanie Dramburg +56 more
wiley +1 more source
Using Lotilaner Ophthalmic Solution, 0.25% to Treat <i>Demodex</i> Blepharitis in Patients Who Were Initially Misdiagnosed: A Case Series. [PDF]
Periman LM +14 more
europepmc +1 more source
ABSTRACT Background IgE‐mediated food allergy burdens individuals, families and healthcare systems. Randomised controlled trials indicate early introduction and regular consumption of common food allergens in infancy can reduce food allergy risk. Few studies have explored parental and healthcare professional experiences. This systematic review examines
Karen Wright +14 more
wiley +1 more source
Pathophysiological and molecular insights into allergic conjunctivitis: an expanding analysis of immunological endotypes. [PDF]
Velazquez-Soto H +5 more
europepmc +1 more source
This is the first randomised placebo‐controlled trial of intralymphatic immunotherapy using a microcrystalline tyrosine‐adjuvanted grass pollen allergoid. Three ultrasound‐guided ILIT injections were well tolerated and reduced combined symptom‐medication scores compared with placebo. The findings support further optimisation and clinical development of
Lara Šošić +13 more
wiley +1 more source
Distinction between allergic rhinitis alone and allergic rhinitis + asthma in MASK-air® real-world studies; a ARIA-WAO task force review. [PDF]
Sousa-Pinto B +31 more
europepmc +1 more source
ABSTRACT These updated EAACI guidelines aim to standardize skin testing methodologies for both immediate and non‐immediate drug hypersensitivity reactions. For immediate reactions, the optimal testing window is 4–6 weeks post‐reaction; whereas beyond 6 months, false‐negative results increase.
Annick Barbaud +14 more
wiley +1 more source
Birch pollen and PM10 are key determinants of clinical symptoms, particularly in asthma. Allergic people react stronger to the pollen collected in the highly polluted area than in the less polluted areas. When evaluating the effectiveness of allergen immunotherapy, it is essential to consider not only pollen concentrations but also levels of air ...
Maria Czarnobilska +5 more
wiley +1 more source
Comparative analysis of microbiota in the ocular surface of patients with atopic keratoconjunctivitis and Stevens-Johnson Syndrome with severe ocular complications. [PDF]
Ueta M +11 more
europepmc +1 more source

